Adjuvant Nivolumab Boosts Survival Outcomes in Muscle-Invasive Bladder Cancer

By News Health
1 month Ago

(MedPage Today) — SAN FRANCISCO — Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of the use of neoadjuvant chemotherapy, according to updated analyses of the CheckMate…

Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/114247

Author :

Publish date : 2025-02-17 18:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Second-Line Treatment for Epilepsy in Women: What Works?

Next Breakthrough in Sickle Cell Therapy?

Assisted dying: Government concerns over timeline

Apology over delay to Nottingham maternity report publication

Sharks aren’t silent after all

Fake pills ease PMS symptoms even when you know they're placebos